CONMED Corp — Director's Dealing 2013

May 3, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2013-05-02

Reporting Person: CORASANTI EUGENE R (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-05-02	Common Stock	M	2500	$29.92	Acquired	72214	Direct
2013-05-02	Common Stock	F	2435	$31.03	Disposed	69779	Direct
2013-05-02	Common Stock	M	2000	$26.69	Acquired	71779	Direct
2013-05-02	Common Stock	F	1795	$31.03	Disposed	69984	Direct
2013-05-02	Common Stock	M	1500	$16.46	Acquired	71484	Direct
2013-05-02	Common Stock	F	983	$31.03	Disposed	70501	Direct
2013-05-02	Common Stock	M	1000	$19.26	Acquired	71501	Direct
2013-05-02	Common Stock	F	722	$31.03	Disposed	70779	Direct
2013-05-02	Common Stock	M	500	$27.63	Acquired	71279	Direct
2013-05-02	Common Stock	F	461	$31.03	Disposed	70818	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-05-02	Sars (Stock Appreciation Rights)	$29.92	M	2500	Disposed	2017-05-17	Common Stock (2500)	Direct
2013-05-02	Sars (Stock Appreciation Rights)	$26.69	M	2000	Disposed	2018-06-01	Common Stock (2000)	Direct
2013-05-02	Sars (Stock Appreciation Rights)	$16.46	M	1500	Disposed	2019-06-01	Common Stock (1500)	Direct
2013-05-02	Sars (Stock Appreciation Rights)	$19.26	M	1000	Disposed	2020-06-01	Common Stock (1000)	Direct
2013-05-02	Sars (Stock Appreciation Rights)	$27.63	M	500	Disposed	2021-06-01	Common Stock (500)	Direct

Footnotes

F1: The stock appreciation rights ("SARs") were granted under the Company's 2006 Stock Incentive Plan and generally vest in equal
amounts over a five year period.

F2: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.